COMP <GO>
JAGX vs UNH // ENTERPRISE SCALE & MARKET CAP
Jaguar Health Inc. (NASDAQ) VS. UnitedHealth Group Incorporated (NYSE) • 15-METRIC TALLY: JAGX 0
— UNH 9
▲ ENTERPRISE SCALE & MARKET CAP LEADER: UNH
LAST: $1.62 (-20.59%) • MKT CAP: $15.9M
market-cap
$15.9M
LAST: $406.97 (-0.96%) • MKT CAP: $368.83B
market-cap
$368.83B
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (JAGX VS. UNH)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | JAGX | UNH | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 67.20% | 88.57% | -21.37 | UNH | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | 11.47% | -46.47 | UNH | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 16.4x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | — | 6.48% | — | TIE | /fcf-yield <GO> |
| Operating Margin | -60.00% | 4.82% | -64.82 | UNH | /operating-margins <GO> |
| Net Profit Margin | -0.50% | 3.14% | -3.64 | UNH | /net-margins <GO> |
| Revenue Growth (YoY) | -1.50% | 6.46% | -7.96 | UNH | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 2.28% | -2.28 | UNH | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | 3.12 | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 1/9 | 7/9 | -6.00 | UNH | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | 6.74% | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 41.6 | 59.2 | -17.60 | UNH | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 0.33 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 17.7x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap ACTIVE | $15.9M | $368.83B | -$368.81B | UNH | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | JAGX REV | UNH REV | JAGX GROSS % | UNH GROSS % | JAGX FCF | UNH FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $11.5M | $447.57B | 67.2% | 88.7% | -$23.7M | $16.07B |
| FY 2024 | $11.7M | $400.28B | 83.3% | 88.3% | -$29.4M | $20.70B |
| FY 2023 | $9.8M | $371.62B | — | 89.6% | -$33.2M | $25.68B |
| FY 2022 | — | $324.16B | — | 89.6% | — | $23.40B |
| FY 2021 | — | $287.60B | — | 89.2% | — | $19.89B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
JAGX // BETA —
UNH // BETA 0.33